National Academies Press: OpenBook

Issues in Risk Assessment (1993)

Chapter: 2.2 Carcinogenic Potency Database (CPDB)

« Previous: 2.1 Measures of Carcinogenic Potency
Suggested Citation:"2.2 Carcinogenic Potency Database (CPDB)." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.

potency ranking and low dose risk assessment. Other investigators have previously proposed linear extrapolation from the TD01 for low dose risk estimation (Mantel & Bryan, 1961; Van Ryzin, 1980; Farmer et al., 1982; Gaylor, 1983).

Another approach to estimating low dose risks is the model-free extrapolation (MFX) method proposed by Krewski et al. (1991a). This procedure assumes only that the dose-response curve is linear at low doses, and is based on a series of secant approximations to the slope of the dose-response curve obtained by linear interpolation between points in the low dose region and controls. Upper confidence limits on the slope of the dose-response curve based on MFX are generally close to the values of q1* obtained from the LMS model. If the dose-response curve is actually sublinear at low doses, the MFX method still provides an upper bound on low dose risks.

In practice, estimation of measures of carcinogenic potency such as the TD50 is not as straightforward as might appear from the preceding discussion. Ideally, estimation of the TD50 should take into account both intercurrent mortality in long-term animal studies and, when available, cause of death information (Finkelstein & Ryan, 1987; Finkelstein, 1991). Sawyer et al. (1984) propose methods for adjusting for intercurrent mortality with rapidly lethal tumors; Portier & Hoel (1987) show that estimates of the TD50 may be biased when the assumption of rapid tumor lethality is not satisfied. Dewanji et al. (1992) proposed a Weibull model that can be used for this purpose, provided that the survival times of individual animals are available for analysis. Bailar & Portier (1992) also use a Weibull model in estimating carcinogenic potency.

2.2 Carcinogenic Potency Database (CPDB)

Gold et al. (1984, 1986a, 1987, 1990) have tabulated the TD50 values for a large number of chemicals which have induced tumors in laboratory animals in their Carcinogenic Potency Database (CPDB). The TD50 values were calculated using statistical methods developed by Sawyer et al. (1984) and Peto et al. (1984) using a one-stage model. All TD 50 values are expressed in common units of mg/kg body weight/day, adjusted to a standard two year rodent lifetime, and corrected for intercurrent mortality whenever individual animal data was available (Gold et al.,

Suggested Citation:"2.2 Carcinogenic Potency Database (CPDB)." National Research Council. 1993. Issues in Risk Assessment. Washington, DC: The National Academies Press. doi: 10.17226/2078.
Page 116
Next: 2.3 Variation in Carcinogen Potency »
Issues in Risk Assessment Get This Book
Buy Paperback | $65.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The scientific basis, inference assumptions, regulatory uses, and research needs in risk assessment are considered in this two-part volume.

The first part, Use of Maximum Tolerated Dose in Animal Bioassays for Carcinogenicity, focuses on whether the maximum tolerated dose should continue to be used in carcinogenesis bioassays. The committee considers several options for modifying current bioassay procedures.

The second part, Two-Stage Models of Carcinogenesis, stems from efforts to identify improved means of cancer risk assessment that have resulted in the development of a mathematical dose-response model based on a paradigm for the biologic phenomena thought to be associated with carcinogenesis.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook,'s online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!